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Abstract
Background: Depressive disorders have been associated with a number of co-morbidities, and we hypothesized
that patients with a depression diagnosis would be heavy users of health care services, not only when first
evaluated for depression, but also for preceding years. The aim of this study was to investigate whether increased
health care utilisation and co-morbidity could be seen during five years prior to an initial diagnosis of depression.
Methods: We used a longitudinal register-based study design. The setting comprised the general population in
the county of Östergötland, south-east Sweden. All 2470 patients who were 20 years or older in 2006 and who
received a new diagnosis of depression (F32 according to ICD-10) in 2006, were selected and followed back to the
year 2001, five years before their depression diagnosis. A control group was randomly selected among those who
were aged 20 years or over in 2006 and who had received no depression diagnosis during the period 2001-2006.
Results: Predictors of a depression diagnosis were a high number of physician visits, female gender, age below 60,
age above 80 and a low socioeconomic status.
Patients who received a diagnosis of depression used twice the amount of health care (e.g. physician visits and
hospital days) during the five year period prior to diagnosis compared to the control group. A particularly strong
increase in health care utilisation was seen the last year before diagnosis. These findings were supported with a
high level of co-morbidity as for example musculoskeletal disorders during the whole five-year period for patients
with a depression diagnosis.
Conclusions: Predictors of a depression diagnosis were a high number of physician visits, female gender, age
below 60, age above 80 and a low socioeconomic status. To find early signs of depression in the clinical setting
and to use a preventive strategy to handle these patients is important.
Background
Depression is one of the most prevalent mental disorders
in the general population [1,2] and is a leading cause of
disease burden in the world [3]. People with a depressive
diagnosis represent a large share of patients using the
health care system, especially in primary care, and their
total health care utilisation is substantial. Other disorders
such as musculoskeletal disorders may co-occur and
precede a depressive diagnosis [4-6]. Co-morbidity is
frequent in a depressive patient group [7].
Depression has also been associated with health pro-
blems such as anxiety, alcohol and drug abuse. In addi-
tion, alcohol disorders have also been suggested as an
important risk factor for mood disorders. Psychosocial
disorders have been pointed out as putative risk factors
for depressive disorders [8]. Further, anxiety disorders
and depressive disorders have been found to share a
similar genetic background [9].
The cumulative life risk for a depression was 23% for
men and 31% for women in the longitudinal Swedish
Lundby study during the period 1972-1997 [10]. Female
gender has been reported as a risk factor for depressive
disorders [11]. Risk factors for depression may also be
poor socioeconomic conditions. Participants with lower
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risk for major depression [12].
The use of antidepressant drugs is frequent in a gen-
eral population and underreporting depressive disorders
and other psychiatric disorders is common. Since the
introduction of selective serotonin reuptake inhibitors
(SSRI) the sales of antidepressant drugs have increased
heavily. A number of studies have demonstrated the effi-
cacy of antidepressants and psychotherapy in treatment
of depression. However, there is a paucity of popula-
tion-based longitudinal studies examining the relation-
ships between depressive disorders, co-morbidity, and
health care utilisation.
We hypothesized that patients who have received a
depressive diagnosis would be heavy users of health care
services, not only when first evaluated for a depression,
but also for several preceding years.
The aim of this study was to investigate whether
increased health care utilisation and co-morbidity could
be seen during five years prior to an initial diagnosis of
depression. Age, gender and socioeconomic status were
i n c l u d e di nt h ea n a l y s e sa sa d j u s t i n gf a c t o r sa sw e l la s
predictors.
Methods
Depression group and control group
In this population-based study we used different linked
population registers of the 440 000 (2006) residents of
t h ec o u n t yo fÖ s t e r g ö t l a n d ,south-east Sweden. Indivi-
dual data on clinical diagnosis, socioeconomic status,
antidepressant drug use, patient costs and health care
utilisation were linked for the whole population. The
personal identification numbers in Sweden facilitate
linking information from different registers.
All 2470 patients who 1) were 20 years of age or older in
2006, 2) had received a diagnosis of depression (F32)
according to the International Classification of Diseases,
10th version (ICD-10) in 2006, and 3) had not been
recorded with related diagnoses (F31-F39) during the pre-
ceding five years (2001-2005) were selected. From the
population we randomly selected a control group of 28500
(out of 251218) persons who were 20 years or older in
2006 and who had no diagnosis of depression during the
period 2001-2006. Patients and controls were residents of
the county council of Östergötland during the whole of
the study period. Confidentiality was ensured by encrypted
numbers and the study was approved by the Regional
Ethical Review Board in Linköping.
Health care utilisation and patient costs
Health care utilisation
The Care Data Warehouse in Östergötland, (CDWÖ)
consists of administrative records of all publicly pro-
duced health care utilisation in the county including
inpatient and outpatient care for all medical specialities
(more than 95% of the health care utilisation in the
county).
For all the visits to a physician and all hospitalisations
in the CDWÖ, it was possible to record up to ten diag-
noses for hospital care and for primary care. All health
care utilisation per patient for the period 2001-2006 was
extracted and expressed by the following variables: total
number of visits to out-patient care including physician
visits (hospital out-patient visits, all GP visits) and visits
to paramedical staff. Besides, the number of hospitalisa-
tion days, in-patient care, was extracted.
Costs per patient (CPP)
The CPP database was linked to CDWÖ and included
costs for each health care contact for every patient who
had been in contact with health services. Costs have been
calculated for all healthcare services, e.g. a visit to a physi-
cian, a nurse or a laboratory test. Thus, it was possible, for
example, to summarize the CPP for healthcare in different
clinics and for each person, over a certain period of time.
We used cost data from 2005-2007 in this study. Typical
unit costs were GP visits (SEK 1655), and physician psy-
chiatric out-patient visits (SEK 2530). We also added drug
costs from the Swedish prescribed Drug Register. All costs
were in SEK (2007 prices).
Drug prescriptions
The Swedish prescribed Drug Register contains all dis-
pensed drug prescriptions and covers the whole Swedish
population. All drugs are classified according to the Ana-
tomical Therapeutic Chemical (ATC) classification sys-
tem. Measurement units of utilisation are prescriptions,
Defined Daily Doses (DDDs) and expenditure. The regis-
ter contains data on drugs (prescribed and dispensed
amount per item for each patient and costs per patient).
In this study all antidepressants (N06A, according to the
ATC system) were selected for the period July 2005 -
December 2007 and prescribed for residents in the
county of Östergötland.
Measure of co-morbidity
Various approaches have been taken to characterize the
combined burden of diseases as single measure on a scale
[13]. We have used The Johns Hopkins Adjusted Clinical
Groups (ACGs) Case-Mix System7.1 to express co-morbid-
ity on an individual level [14]. This system has prior been
used in Sweden [15-17] and found to have a good validity
in predicting health care utilisation. The assumption is that
the pattern of diagnoses, rather than single diagnoses,
shows the level of co-morbidity. The aim is to take not only
t h ep r e s e n c eb u ta l s ot h es e v e r i t yo fd i f f e r e n td i a g n o s e s
into account. The calculations are made for diagnosis over
a specified period of time, yearly in this study. All primary
care and secondary care diagnoses that the patients had
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lysis of co-morbidity level using the ACGs. Each of the indi-
viduals in the population was assigned to one of 92 ACGs
and was expressed in Reference Rescaled Concurrent
Weight (RRCW) according to the Case-Mix System7.1.
The RRCW is constructed so that 1 is the mean of the
population. A value larger than 1 means that a person is
expected to cost more than average and has a higher degree
of co-morbidity, while a value less than 1 indicates the
opposite. A normal population (in our study the same as
the control group) is expected to have a value of 1.
Socioeconomic status
Statistics Sweden has created a Total Population Regis-
ter. This register is mainly used as a basic register for
preparation of statistics in the Swedish counties and
municipalities regarding the size and composition of the
population, stratified according to sex, age, marital sta-
tus, etc. We have used individual data from this register
for the variables age, gender and income.
A socioeconomic index for each resident has been cre-
ated and used in the county of Östergötland, based on
income for small geographical areas in the county. The
index consists of five socioeconomic categories. The
variable has been validated and has shown a high asso-
ciation with other socioeconomic variables: (the propor-
tion of) senior citizens, immigrants, unemployed, low
education, low income, block of flats and social assis-
tance in small geographical areas [18].
Statistical analysis
Pearson’s Chi-Square test was used to analyse differ-
ences in the distribution of the basic variables for the
group with a depression diagnosis and the control
group. The mean values and confidence intervals for
physician visits and co-morbidity (RRCW) in the depres-
sion and control group (Figures 1, 2, 3) were adjusted
for background variables (gender, age and socioeco-
nomic status). This was done using analysis of covar-
iance and the means were adjusted to the distribution of
background variables in the depression diagnosis group
[19]. Logistic regression was used to calculate the odds
ratios for a depression diagnosis (i.e. coding the
response variable 1 for depression diagnosis and 0 for
controls) comparing the impact of gender, age, socioeco-
nomic status, co-morbidity (RRCW) and physician visits.
We tested for all two-way interactions in order to vali-
date the regression model.
Results
Women were more likely to receive a depression diag-
nosis than men (Table 1). Patients with a depression
diagnosis were both younger and older than patients in
the control group but with a lower proportion of middle
aged. A difference was also seen in socioeconomic sta-
tus, with a higher proportion of patients with a depres-
sion diagnosis for the two lowest socioeconomic
categories. Physician visits five years as well as one year
prior to diagnosis were more frequent in the group with
a depression diagnosis than in the controls.
Figure 1 Total number of physician visits per person by year
prior to depression diagnosis. Adjusted for gender, age and
socioeconomic status.
Figure 2 Total number of days in inpatient care per person by
year prior to depression diagnosis. Adjusted for gender, age and
socioeconomic status.
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and socioeconomic status, patients with a depression
diagnosis had a higher number of physician visits per
person all five years prior to the diagnosis (Figure 1).
The difference was largest the last year prior to the
depression diagnosis. When analysing visits to general
practitioners separately from visits to specialists the
results paralleled those of total physician visits (data not
shown). Similar differences between the group with a
depression diagnosis and the control group could be
seen for the number of hospitalization days per patient
(Figure 2).
The group with a depression diagnosis showed a sig-
nificantly higher co-morbidity level during the whole
five-year period (Figure 3). The control group was situ-
ated at RRCW level 1, which was the expected level for
a normal population. The most dominant co-morbidity
diagnoses emanated from the musculoskeletal system.
Sixty percent of the patients with a depression diagnosis
were suffering from musculoskeletal disorders during
the period 2001-2006. The corresponding number for
the control group was 45%. A high frequency of co-
morbidity was also seen for cardiovascular diseases; 36%
in the group with a depression diagnosis and 29% in the
control group during the period 2001-2005. A high
increase in co-morbidity was registered in the year prior
to diagnosis of depression.
In multiple logistic regression analyses the likelihood
of receiving a depression diagnosis in 2006 was asso-
ciated with a high number of physician visits five years
prior to diagnosis, low socioeconomic status, age below
60, age above 80 and female gender (Model 1, Table 2).
The odds ratios for a depression diagnosis were substan-
tially higher when the physician visits the year before
diagnosis was considered (Model 2, Table 2). The physi-
cian visits five years before diagnosis was statistically sig-
nificant even when adjusting for the number of visits the
year before diagnosis but the odds ratios were rather
low (Model 3, Table 2).
In further analyses all two-way interactions between
ages, gender, socioeconomic status and physician visits
were included in the model but none was found statisti-
cally significant. We also analysed each of the other vari-
ables related to health care utilisation (RRCW level,
hospital days and total number of visits) in logistic
regression models. However, the results were similar to
that for physician visits (data not shown). In additional
logistic regression analyses, RRCW was not significantly
associated with depression diagnosis when adjusting for
physician visits. It should be noted, that RRCW and phy-
sician visits were highly correlated (Spearman rho > 0.88
for each year 2001 to 2005).
The group with a depression diagnosis in our study
spent almost twice the amount of health care costs the
year before diagnosis compared with the control group
(SEK
25600 per patient compared with SEK 13 400 per
patient). The year after diagnosis the costs were more
than three times higher: SEK 44300 for the patients with
a depression diagnosis compared with SEK 14100 for
the controls. The amount of health care costs consisted
of in-patient care, out-patient care and drugs.
Discussion
Predictors of a depression diagnosis were a high number
of physician visits, female gender, age below 60, age
above 80 and a low socioeconomic status.
Patients who received a diagnosis of depression used
twice the amount of health care (e.g. physician visits and
hospital days) during the five year period prior to diagno-
sis compared to the control group. A particularly strong
increase in health care utilisation was seen the last year
before diagnosis. These findings were supported with a
high level of co-morbidity in terms of both RRCW and
particular diagnoses, as for example musculoskeletal dis-
orders, during the whole five-year period for patients
with a depression diagnosis.
Co-morbidity was an important factor in order to
explain the high level of resource use for patients with a
depression disease. From many studies it is known that
the musculoskeletal system is overrepresented in
patients who later receive a depression diagnosis [4].
The same is valid for the patients with problems from
the cardio-vascular system [7]. This fact was also
Figure 3 Level of co-morbidity (RRCW) by year prior to
depression diagnosis. Adjusted for gender, age and
socioeconomic status.
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depression diagnosis also suffered from musculoskeletal
disorders and 36% had a cardiovascular disease before
getting the depression diagnosis.
Depressions are more common in midlife than in the
elderly. However, depressive symptoms are more fre-
quent among the oldest old explained by factors asso-
ciated by aging such as co-morbidity [20]. This is also
seen in our data: odds ratios were highest in young ages
and decreasing in the elderly and finally with a peak in
the oldest old (but with lower odds ratios than in mid-
life). More adjustment for co-morbidity (i.e. physician
visits) reduced the depression odds ratio in the older
groups illustrating that co-morbidity is an important fac-
tor especially in the oldest old (Model 3 versus Model 1,
Table 2).
Psychiatric diagnoses have been found to be underre-
ported in registers, especially in primary care [21]. Drug
use, might be another important indicator of high health
care utilisation and also a predictor of a future depres-
sion diagnosis. Hence, the use of drugs with a somatic
indication has been found to be on a high level several
years before treatment with antidepressants and prior to
a psychiatric diagnosis [22].
In the study by Bingefors et al [22], only 45% of antide-
pressant-treated patients had a recorded psychiatric diag-
nosis. But when the medical records for these patients
were further scrutinised 80% had depressive symptoms
or a diagnosis of a depressive disorder. In our study it
was shown that patients treated with antidepressants
used more than twice as many health care resources as
controls. Earlier studies of depression patients have
shown a high concurrent use of health care resources,
also for somatic complaints [23].
In our study almost 30% of the patients in the group
with a depression diagnosis were treated with antidepres-
sants during the year before diagnosis, with a majority of
the patients between 45 and 60 years of age. The
Table 1 Background characteristics of the patients with a depression diagnosis and the control group
Depression diagnosis (n = 2470) Control group (n = 28500)
% % Pearson Chi-Square P
Gender 212.9 <.0001
Women 64.1 48.8
Men 35.9 51.2
Age 71.2 <.0001
20-29 14.2 12.2
30-39 17.2 16.0
40-49 17.1 18.2
50-59 17.0 18.5
60-69 12.5 16.8
70-79 10.5 10.2
80+ 11.5 8.1
Socioeconomic status 65.2 <.0001
Highest 6.0 7.6
Second highest 18.3 21.8
Middle 36.5 38.9
Second lowest 25.7 21.6
Lowest 13.5 10.1
Physician visits in 2001 299.6 <.0001
0 26.1 38.8
1-2 33.8 35.5
3-4 19.6 14.0
5-7 12.8 7.8
8+ 7.7 3.8
Physician visits in 2005 1162.7 <.0001
0 15.7 45.0
1-2 29.6 27.5
3-4 21.1 14.0
5-7 19.8 8.5
8+ 13.9 5.0
TOTAL 100.0 100.0
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Our finding that not all of the patients with a depression
diagnosis receive antidepressants is in line with other stu-
dies [24].
Treatment with antidepressants increased to more
than 80% of the patients the year after the depression
diagnosis was given, compared with 7% in the control
group.
This implies that 20% of the patients with a depres-
sion diagnosis were still not treated with an antidepres-
sant drug. Some of these patients may have been treated
with other alternatives such as physiotherapy or cogni-
tive behavioural therapy.
The discrepancy between psychiatric diagnoses and the
antidepressant drug use might be explained by doctors
and patients behaviour. Health care providers may record
the same condition with a variety of cods and it might be
possible that a depressive health status was present before
the depression diagnosis put in the medical records. A
somatic diagnosis might have been used instead because
psychiatric conditions might still be stigmatized by society
and patients would perhaps rather see their primary physi-
cians than psychiatric specialists.
There is a lack of population-based longitudinal studies
examining the relationships co-morbidity, and health
care utilisation. However, in a similar investigation com-
p a r e dt oo u rs t u d yi tw a sf o u n dt h a to b s t r u c t i v es l e e p
apnea syndrome patients have symptoms, high health
care utilisation and co-morbidities as far back as ten
years before recognition of their disorder [25].
Table 2 Adjusted odds ratios for a depression diagnosis in relation to socio-demographic variables and prior physician
visits
Model 1 Model 2 Model 3
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Gender
Men REF REF REF
Women 1.72 (1.57 - 1.87) <.0001 1.52 (1.40 - 1.67) <.0001 1.50 (1.37 - 1.64) <.0001
Age <.0001 <.0001 <.0001
20-29 1.65 (1.41 - 1.94) <.0001 1.95 (1.66 - 2.30) <.0001 1.99 (1.68 - 2.34) <.0001
30-39 1.57 (1.34 - 1.83) <.0001 1.82 (1.56 - 2.13) <.0001 1.85 (1.58 - 2.16) <.0001
40-49 1.36 (1.17 - 1.59) <.0001 1.65 (1.41 - 1.93) <.0001 1.66 (1.42 - 1.94) <.0001
50-59 1.32 (1.13 - 1.54) 0.0004 1.44 (1.23 - 1.68) <.0001 1.45 (1.24 - 1.70) <.0001
60-69 REF REF REF
70-79 1.22 (1.02 - 1.45) 0.0275 1.07 (0.90 - 1.27) 0.4683 1.06 (0.89 - 1.26) 0.5096
80+ 1.48 (1.25 - 1.76) <.0001 1.31 (1.10 - 1.56) 0.0022 1.28 (1.08 - 1.52) 0.0053
Socioeconomic status <.0001 <.0001 <.0001
Highest REF REF REF
Second highest 1.04 (0.86 - 1.26) 0.6905 1.04 (0.86 - 1.27) 0.6844 1.04 (0.85 - 1.26) 0.7170
Middle 1.14 (0.95 - 1.36) 0.1648 1.14 (0.94 - 1.36) 0.1788 1.13 (0.94 - 1.35) 0.2052
Second lowest 1.41 (1.17 - 1.70) 0.0004 1.40 (1.16 - 1.70) 0.0005 1.39 (1.15 - 1.68) 0.0007
Lowest 1.53 (1.25 - 1.88) <.0001 1.45 (1.18 - 1.78) 0.0005 1.43 (1.16 - 1.76) 0.0008
Physician visits in 2001 <.0001 0.0007
0 REF REF
1-2 1.35 (1.22 - 1.51) <.0001 1.06 (0.95 - 1.18) 0.3074
3-4 1.92 (1.69 - 2.17) <.0001 1.26 (1.10 - 1.43) 0.0007
5-7 2.25 (1.95 - 2.60) <.0001 1.28 (1.10 - 1.49) 0.0014
8+ 2.63 (2.20 - 3.15) <.0001 1.26 (1.04 - 1.52) 0.0163
Physician visits in 2005 <.0001 <.0001
0 REF REF
1-2 3.07 (2.70 - 3.49) <.0001 2.98 (2.61 - 3.39) <.0001
3-4 4.35 (3.79 - 5.00) <.0001 4.12 (3.57 - 4.75) <.0001
5-7 6.81 (5.89 - 7.87) <.0001 6.34 (5.46 - 7.36) <.0001
8+ 8.31 (7.07 - 9.76) <.0001 7.57 (6.40 - 8.96) <.0001
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databases and the linkage to other registers. The use of a
personal identification number made it possible to follow
individuals and there was total population coverage. The
possibility to follow health care utilisation on an individual
level during a long period of time even in primary care
was a great advantage in this study. When using registers,
sources of bias such as recall bias, response bias and selec-
tion bias could be kept at a minimum. An additional
strength was the size of the study, with more than 2400
patients having a new diagnosis of depression. The study
size results in a high power for the analysis of interactions
and, since none of those were even close to significant,
our results indicate that the stability of the associations
between health care utilisation and later depression diag-
nosis over age groups, gender, and socio-economic status
is high.
A weakness of using registers is the quality of data
and the broad clinical variation, for instance variation in
the definition of depression. This might create a bias
and an uncertainty in the cohort of depression
diagnosis.
The co-morbidity concept is complex and there is a lack
of consensus about how to define and measure the con-
cept. Other concepts are multi-morbidity, burden of dis-
ease and frailty, especially in the geriatric field [13]. Often
these concepts are multidimensional and more compre-
hensive compared to the measure RRCW we have used in
the present study. However, the ACG instrument has been
used and been found of a good validity in a Swedish set-
ting [15] and it was easy to handle in our study. In this
study the number of physician visits and RRCW were
highly correlated, which is not so unexpected since RRCW
is constructed to predict health care utilisation. One con-
sequence was that physician visits and RRCW could not
be included in a regression model simultaneously without
a considerable loss in statistical power.
There are several factors associated with the heavy
health care utilisation among patients with a depression
diagnosis. We adjusted for well-known factors associated
with high health care utilisation such as a low socioeco-
nomic status and female gender [26]. Female gender
usually has a high use of health care resources and it is
well-known that women have a high incidence and pre-
valence of depressive disorders [10]. A weakness of study
is that we only analyzed patient-related variables and not
provider-related variables such as location of health care
units (rural or urban), privateo rp u b l i cc a r e ,r e m u n e r a -
tion system, etc. which might influence health care utili-
sation. However the Swedish health care system and the
County Council of Östergötland was (in 2006) rather
homogenous, geographically and economically, and was
dominated by public providers and a health care person-
nel who was salaried.
Patients with a depressive diagnosis represent a large
share of patients in health care, especially in primary
care. GPs are nowadays confronted with an increasing
multi morbidity of an aging population and they are
under pressure of psychiatric hospitals which seek to
integrate their patients in the local community. The
organizational format is to attach different professionals
to GP practices. A central obstacle in Swedish health
care is that clinical services are the responsibility of
county council while care for social needs is the respon-
sibility of the local municipalities. Besides, there is no
GP gate-keeper system in Sweden. However, a new
reform: “choice of care” for citizens has been introduced
within primary care where different actors, both public
and private, provide services as long as certain quality
criteria are met. Today primary care services are there-
fore provided by a mix of public and private actors
which may influence clinical management and some-
times create delays in the health care processes. How-
ever, there are also recent organisational incentives to
convince primary care, specialist care and social care to
create “chains of care” for chronically ill persons and
patients with multi morbidity.
In this study we found that early signs of a depression
diagnoses were a high number of physician visits, female
gender, age below 60, age above 80 and a low socioeco-
nomic status. The incentives to create chains of care
might therefore include and integrate our findings in
order to prevent delays in the clinical patient manage-
ment. Early diagnosis and treatment of patient with
depressive disorders would improve the health situation
of these patients and may reduce the financial burden of
health care providers and taxpayers. The effectiveness of
pharmacological treatment of depressive disorders is gen-
erally accepted, and most patients who are treated experi-
ence a strong improvement in their quality of life and are
able to take part in a daily working life.
To conclude, the high level of co-morbidity during the
whole five-year period for patients with a new depres-
sion diagnosis had a heavy impact on health care utilisa-
tion. Caution should be exercised in the GP surgery
when meeting a young or very old woman with a low
socioeconomic status and many physician visits within a
short time-period. Early detection and adequate treat-
ment of these patients may reduce high health care utili-
sation and improve the quality of life for this group of
patients.
Conclusions
Predictors of a depression diagnosis were a high number
of physician visits, female gender, age below 60, age
above 80 and a low socioeconomic status. To find early
signs of depression in the clinical setting and to use a
preventive strategy to handle these patients is important.
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